chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 5.0
Sex: M
Vaccine: FLUN4
Symptoms: Influenza
Clinical narrative: A report has been received from a Physician concerning a seven year old, male subject, who had been receiving FLUMIST (intranasal). Patient relevant history and concurrent diseases were not reported. Concomitant medications were not reported. FLUMIST QUADRIVALENT (intranasal) started on an unknown date. Patient's mother reported that the patient was diagnosed with flu after receiving FLUMIST which started during Aug-2012. Consumer mother stated that her 2 children received FLUMIST in Aug-2012 and one child diagnosed with Type A in Jan-2013 and the other diagnosed the Type A and B shortly after. The outcome of the event of children got the flu after receiving FLUMIST was unknown. The report was considered to be non-serious.
Age: 65.0
Sex: M
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Health Professional concerning a 65 year old, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 01-Oct-2014. It was reported that the FLUMIST QUADRIVALENT was administered to four patients over the age of 49 which started on 01-Oct-2014. The outcome of the event of inadvertent administration of FLUMIST QUADRIVALENT to patient over 49 years of age is unknown. The report was considered to be non-serious.
Age: 35.0
Sex: M
Vaccine: FLUN4
Symptoms: Drug administration error
Clinical narrative: A report has been received from a health professional who was a registered nurse. The report concerns a 35 year old male patient. The patient's medical history, concurrent diseases and concomitant medications were not reported. The patient received FLUMIST QUADRIVALENT (intranasal) at an unknown dose on 22-Oct-2014. The registered nurse reported that on 22-Oct-2014 during administration the clip came off and the entire contents of the sprayer went into one nostril and dribbled out. Action taken with FLUMIST QUADRIVALENT was unknown. The outcome of the event of entire contents of sprayer administered in one nostril and dribbled out was unknown. The report was considered to be non-serious by the reporter.
Age: 4.0
Sex: M
Vaccine: FLUN4
Symptoms: Extra dose administered
Clinical narrative: A report has been received from a Health Professional concerning a male patient. No medical history and concomitant medications provided. The patient had been receiving FLUMIST QUADRIVALENT (intranasal) started on 03-Sep-2014. Patient inadvertently received a dose of FLUMIST on 03-Sep-2014 and 15-Sep-2014. Patient was doing fine. Next follow up was scheduled for 15-Oct-14. The outcome of the event of patient inadvertently received a dose of FLUMIST on 09/03/2014 and again on 09/15/2014 was unknown. The reporter considered the case to be non serious.
Age: 4.0
Sex: F
Vaccine: FLUN4
Symptoms: Wheezing
Clinical narrative: A report has been received from a health professional via medical representative concerning a 4 year old female patient. No medical history, concomitant disease and concomitant medications were reported for patient. Patient had received FLUMIST QUADRIVALENT (intranasal) on 15-Sep-2014. Medical representative reported that nurse reported him that a patient received FLUMIST QUADRIVALENT (intranasal) on 15-Sep-2014 and had wheezing symptoms on 17-Sep-2014. Action taken was not applicable for FLUMIST QUADRIVALENT. The patient received treatment and the symptoms resolved two days later. The patient was currently doing fine. The report was considered to be non-serious by reporter.
Sex: U
Vaccine: FLUN4
Symptoms: Drug administration error
Clinical narrative: A report has been received from a Health Professional concerning a patient of unknown gender. No medical history provided. The patient had been receiving FLUMIST QUADRIVALENT (intranasal) started on an unknown date. Nurse practitioner wanted to know if a child had the entire dose of FLUMIST given in one nostril, should the dose be repeated. No symptoms to report. The patient had entire dose of FLUMIST given in one nostril. The outcome of the event of entire dose of FLUMIST given in one nostril was unknown. The reporter considered event of entire dose of FLUMIST given in one nostril to be non-serious.
Age: 9.0
Sex: M
Vaccine: FLUN4
Symptoms: Drug administration error
Clinical narrative: A report has been received from a Pharmacist concerning a 9 year old, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 05-Oct-2014. The patient inadvertently administered all the FLUMIST QUADRIVALENT dose in one nostril to two patients which started on 05-Oct-2014. The outcome of the event of inadvertently administered all the FLUMIST QUADRIVALENT dose in one nostril to two patients is unknown. The report was considered to be non-serious.
Age: 50.0
Sex: F
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Health Professional concerning a 50 year old, female subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 26-Oct-2014. 50 year old patient received FLUMIST QUADRIVALENT. The outcome of the event of 50 year old patient received FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Sex: U
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Pharmacist concerning an adult, subject of unknown gender, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. It was reported that a patient over 49 YOA received FLUMIST QUADRIVALENT. The outcome of the event of patient over 49 years of age received FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious. Follow-up of insignificant information received by AstraZeneca/MedImmune 11-Nov-2014: reporters details updated. Narrative updated.
Age: 1.25
Sex: M
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Health Professional concerning a 1 year old, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. It was reported that the patient experienced inadvertently administered FLUMIST QUADRIVALENT to a 15 month old which started on 27-Oct-2014. The outcome of the event of inadvertently administered FLUMIST QUADRIVALENT to a 15 month old is unknown. The report was considered to be non-serious.
Age: 1.69
Sex: F
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Health Professional concerning a 1 year old, Female subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent started on 06-Oct-2014. HCP stated that 20 Month Old Patient Inadvertently Received FLUMIST. The outcome of the event of 20 month old patient inadvertently received FLUMIST is unknown. The report was considered to be non-serious.
Age: 16.0
Sex: F
Vaccine: FLUN4
Symptoms: Exposure during pregnancy
Clinical narrative: A report has been received from a Medical Rep concerning a 16 year old, female subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started during Oct-2014. 16 year old pregnant patient on October 6 or 7, 2014 inadvertently administered by FLUMIST QUADRIVALENT. The outcome of the event of pregnant 16 year old received FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Age: 3.0
Sex: F
Vaccine: FLUN4
Symptoms: Rash
Clinical narrative: A report has been received from a Health Professional concerning a patient, female subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 24-Oct-2014. The patient experienced two patients experienced rash 24 hours after receiving FLUMIST, one had rash on the face, the other on the trunk. The outcome of the event of two patients experienced rash 24 hours after receiving FLUMIST, one had rash on the face, the other on the trunk is unknown. The report was considered to be non-serious.
Age: 35.0
Sex: F
Vaccine: FLUN4
Symptoms: Drug administration error
Clinical narrative: A report has been received from a Pharmacist concerning a female. No information regarding relevant history, concomitant disease and concomitant medications were provided. It was reported that when administering the second part of the FLUMIST QUADRIVALENT (intranasal) dose in the second nostril (L) the second half-dose came completely out of the nose. No reactions were observed at the time of administration on 01-Oct-2014. The outcome of the event of second half dose of FLUMIST QUADRIVALENT came completely out of the second nostril was unknown. The reporter considered the event to be non-serious.
Age: 60.0
Sex: F
Vaccine: FLUN4
Symptoms: Off label use
Clinical narrative: A report has been received from a Health Professional concerning a 60 year old, female subject, who had been receiving QLAIV (intranasal). Concomitant medications included levothyroxine sodium, pantoprazole, lorazepam, clonidine, rosuvastatin, venlafaxine, ramipril and quetiapine. FLUMIST (intranasal) started on an unknown date. It was reported that a pharmacist dispensed the FLUMIST vaccine to the wrong patient population. The patient recovered from the event of off label administration of FLUMIST QLAIV on 28-Oct-2014. The reporter's description of the event(s) was as follows: no medical history. The report was considered to be non-serious. The reporter has considered that the event of off label administration of FLUMIST QLAIV to be unrelated to the suspect drug. The reporter considered that there was no causal relationship between off label administration of FLUMIST QLAIV and QLAIV. As a Medical Advisor, I have considered the causality between the event off label administration of FLUMIST QLAIV with the suspect drug of QLAIV to be No.
Age: 7.0
Sex: M
Vaccine: FLUN4
Symptoms: Drug administration error
Clinical narrative: A report has been received from a pharmacist concerning a 7 year old male patient. No concomitant drugs or relevant history was provided. The patient had been receiving FLUMIST QUADRIVALENT (intranasal) started on an unknown date. The patient was administered FLUMIST in one nostril on 28-Sep-2014. The outcome of the event of administered FLUMIST in one nostril was unknown. The report was considered to be non-serious by the reporter.
Age: 7.0
Sex: M
Vaccine: FLUN4
Symptoms: Extra dose administered
Clinical narrative: A report has been received from a Health Professional concerning a 7 year old, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. It was reported that the patient was dosed twice with FLUMIST QUADRIVALENT on 27-Oct-2014 and 28-Oct-2014. The outcome of the event of dosed twice with FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Age: 42.0
Sex: F
Vaccine: FLUN4
Symptoms: Underdose
Clinical narrative: A report has been received from a health professional concerning a 42 year old, female subject, who had been receiving FLUMIST Quadrivalent. FLUMIST Quadrivalent started on 22-OCT-2014. It was reported that the patient had received only half dose of FLUMIST Quadrivalent in one nostril which started on 22-OCT-2014. The outcome of the event received a half dose of FLUMIST Quadrivalent is unknown. The report was considered to be non-serious.
Sex: F
Vaccine: FLUN4
Symptoms: Unevaluable event
Clinical narrative: A report has been received from a Pharmacist concerning a patient born on 29-SEP-1998, female subject, who had been receiving FLUMIST Quadrivalent. The patient's concurrent disease(s) include Viral hepatitis. FLUMIST Quadrivalent  started on an unknown date. It was reported that FLUMIST Quadrivalent was administered to a patient who they thought had viral hepatitis. The outcome of the event of gave FLUMIST Quadrivalent to patient with Viral hepatitis is unknown. The report was considered to be non-serious.
Age: 6.0
Sex: M
Vaccine: FLUN4
Symptoms: Pyrexia
Clinical narrative: A report has been received from a Health Professional concerning a 5 year old, male subject, who had been receiving intramuscular FLUMIST QUADRIVALENT (Intranasal). FLUMIST QUADRIVALENT(intranasal) started on 27-Oct-2014. The patient experienced fever of 100.5F which started on 27-Oct-2014. The outcome of the event of fever of 100.5F is unknown. The report was considered to non-serious.
Sex: F
Vaccine: FLUN4
Symptoms: Nasal discomfort, Sinusitis
Clinical narrative: A spontaneous report has been received from a Pharmacist concerning an adult, female patient of unknown ethnicity. The relevant history and concomitant disease of the patient were not reported. The concomitant medications of the patient were not provided. Pharmacist reported that the patient stated she had a sinus infection and burning in her nose after receiving last years  FLUMIST Quadrivalent started on an unknown date. Action taken was not applicable for FLUMIST and the outcomes of the events were unknown. The vents, sinus infection and burning in her nose after last years FLUMIST considered to be non serious by the reporter.
Age: 7.0
Sex: M
Vaccine: FLUN4
Symptoms: Influenza virus test positive
Clinical narrative: A report has been received from a health professional concerning a 7 year old , male subject, who had been receiving FLUMIST Quadrivalent. FLUMIST Quadrivalent started on an unknown date. The patient experienced patient tested positive for influenza which started on 27-OCT-2014. The outcome of the event of patient tested positive for influenza is unknown. The report was considered to be non-serious.
Age: 1.8
Sex: F
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a health professional concerning a 1 year od, female subject, who had been receiving FLUMIST Quadrivalent. FLUMIST Quadrivalent started on an unknown date. It was reported that the administration to 20 month old which started on 21 OCT 2013. The outcome of the event of administration to 20 month old is unknown. The report was considered to be non-serious.
Age: 1.6
Sex: F
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a health professional concerning a 1  year old, female subject, who had been receiving FLUMIST Quadrivalent. FLUMIST Quadrivalent started on an unknown date. It was reported  that a patient was inadvertently administered FLUMIST Quadrivalent to a 18 month old child. The outcome of the event of Administered FLUMIST Quadrivalent to an 18 month old is unknown. The report was considered to be non-serious.
Age: 67.0
Sex: F
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a health professional concerning a 67 year old, Female subject, who had been receiving FLUMIST Quadrivalent. FLUMIST Quadrivalent started on an unknown age. It was reported that a patient had received FLUMIST Quadrivalent and was over 49 years old. The outcome of the event of inadvertent administration of FLUMIST Quadrivalent to patient over 49 years of age is unknown. The report was considered to be non-serous.
Sex: U
Vaccine: FLUN4
Symptoms: Rhinalgia
Clinical narrative: A report has been received from a physician concerning a child, subject of unknown gender, who had been receiving FLUMIST Quadrivalent. FLUMIST Quadrivalent started on an unknown date. Th4e patient experienced stinging in nose. The outcome of the event of stinging in nose is unknown. The report was considered to be non-serious.
Age: 46.0
Sex: F
Vaccine: FLUX
Symptoms: Activities of daily living impaired, Discomfort, Ear swelling, Eye swelling, Lip swelling
Clinical narrative: A report has been received from consumer concerning a 46 year old female patient. No medical history provided. The patient has no health problems in general. The patient had been receiving unknown influenza virus 120 for influenza immunization started on 23-OCT-2013. The patient experienced urticaria. Reporter had quite a few hives attack after the flu vaccine, subsequently caused swelling in the mouth , huge swelling around the left eye and huge swelling on the right ear. So uncomfortable that she had to call in sick because she firstly looked terrible and secondly it was so incredibly uncomfortable. The patient had not been treated for the adverse reaction. The patient had been admitted to hospital because of adverse reaction. No investigation conducted nor was any laboratory test taken. Action taken with the suspect was unknown. At the time of reporting the event of ear swelling, urticaria, eye swelling, to swelling and swollen mouth was ongoing. The reporter considered the case to be non-serious.
Age: 46.0
Sex: F
Vaccine: FLUX
Symptoms: Mouth swelling, Urticaria
Clinical narrative: A report has been received from consumer concerning a 46 year old female patient. No medical history provided. The patient has no health problems in general. The patient had been receiving unknown influenza virus 120 for influenza immunization started on 23-OCT-2013. The patient experienced urticaria. Reporter had quite a few hives attack after the flu vaccine, subsequently caused swelling in the mouth , huge swelling around the left eye and huge swelling on the right ear. So uncomfortable that she had to call in sick because she firstly looked terrible and secondly it was so incredibly uncomfortable. The patient had not been treated for the adverse reaction. The patient had been admitted to hospital because of adverse reaction. No investigation conducted nor was any laboratory test taken. Action taken with the suspect was unknown. At the time of reporting the event of ear swelling, urticaria, eye swelling, to swelling and swollen mouth was ongoing. The reporter considered the case to be non-serious.
Sex: U
Vaccine: FLUN3
Symptoms: Pyrexia
Clinical narrative: A report has been received from a health professing concerning a subject of unknown gender, who had been receiving FLUMIST. FLUMIST started on an unknown date. The patient experienced fever. The outcome of the event of fever is unknown. The report was considered to be non-serious by the reporter.
Sex: U
Vaccine: FLUN3
Symptoms: Cough
Clinical narrative: A report has been received from a Physician concerning a child, subject of unknown gender, who had been receiving FLUMIST (intranasal). FLUMIST (intranasal) started on an unknown date. The patient experienced cough. The outcome of the event of cough is unknown. The report was considered to be non-serious by the reporter.
Sex: M
Vaccine: FLUN3
Symptoms: Condition aggravated, Wheezing
Clinical narrative: A report has been received from a health professional via a medical representative concerning an 11 or 12 year old male. The medical history included wheezing, and concurrent disease included asthma. The patient received FLUMIST (intranasal) on an unknown date. In September or Oct-2010, the patient experienced wheezing and was subsequently sent to the hospital. The patient recovered from the event of wheezing on an unspecified date. The reporter considered the event of wheezing as serious due to important medical event criterion. Summary of follow-up information received by AstraZeneca/MedImmune on 26-Sep-2014 from health professional: drug as reported was updated from FLUMIST QUADRIVALENT to FLUMIST, medical history and event outcome updated. Corrected report 02-Oct-2014: source of report was updated to spontaneous, reporter information updated, event onset date added.
Age: 9.0
Sex: F
Vaccine: FLUN4
Symptoms: Rash
Clinical narrative: A report has been received from a Health Professional concerning a patient, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 15-Oct-2014. The patient experienced rash on the trunk. The patient recovered from the event of rash on the trunk on an unspecified date. The report was considered to be non-serious.
Age: 5.0
Sex: M
Vaccine: FLUN4
Symptoms: Extra dose administered
Clinical narrative: A report has been received from a Health Professional concerning a 5 year old, male patient. No relevant medical history and concomitant medications provided. The patient had been receiving FLUMIST QUADRIVALENT (intranasal) started during 2014. The patient received two flu vaccines. Nurse stated that the patient received FLUMIST on 24-Oct-2014 and afterwards she found out that he had received another influenza vaccination 19-20 days prior. She did not know what type of vaccines was the first, nasal or injectable. Action taken with suspect was unknown. The outcome of the event of child received two flu vaccines was unknown. The reporter considered the event of child received two flu vaccines to be non-serious.
Age: 37.0
Sex: F
Vaccine: FLUN4
Symptoms: Drug administration error, No adverse event
Clinical narrative: A report has been received from a Pharmacist concerning a 37 year old female patient. No information regarding relevant history, concomitant disease and concomitant medications were provided. The patient received FLUMIST QUADRIVALENT (intranasal) on 24-Oct-2014. The pharmacist reported that they accidentally administered FLUMIST QUADRIVALENT into one nostril of a patient. Patient had not reported any adverse effects. The outcome of the event of accidentally administered FLUMIST QUADRIVALENT into one nostril of a patient was unknown. The reporter considered the event to be non-serious.
Age: 6.0
Sex: M
Vaccine: FLUN4
Symptoms: Chills, Cough, Headache, Pyrexia
Clinical narrative: A report has been received from a Physician concerning a 6 year old male subject, who had been receiving FLUMIST QUADRIVALENT.  FLUMIST QUADRIVALENT started on 23-OCT-2014. The patient experienced fever, chills, cough and headache which started on 25-OCT-2014. At the time of reporting the event of fever, chills, cough and headache was ongoing. The report was considered to be non-serious.
Age: 15.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report has been received from a Health Professional concerning a 15 year old, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 24-Oct-2014. Expired FLUMIST QUADRIVALENT was administered to two patients which started on 24-Oct-2014. The outcome of the event of expired FLUMIST QUADRIVALENT administered to two patients is unknown. The report was considered to be non-serious.
Age: 43.0
Sex: F
Vaccine: FLUN4
Symptoms: Blood thyroid stimulating hormone normal, C-reactive protein normal, Cough, Influenza like illness, Nasal congestion
Clinical narrative: A report has been received from a Physician concerning a 43 year old female. No medical history and concomitant medications provided. The patient had been receiving FLUMIST QUADRIVALENT 2 ml started on 17 OCT 2014 with Lot number CJ2129 and expiration date was 05-JAN-2015. The patient received FLUMIST QUADRIVALENT and a few days later reported flu like symptoms/flu like symptoms which started on 21-OCT-2014 and nasal congestion, cough, sore throat, aching and fever. The patient had sought increase platelet count which started during 21-OCT-2014. The patient recovered from the event of patient received FLUMIST QUADRIVALENT and a few days later reported flu like symptoms/flu like symptoms on an unspecified date and the outcome of the event of nasal congestion, cough, sore throat, aching, slight increase platelet count and fever was unknown. The reporter considered the events of patient received FLUMIST QUADRIVALENT and a few days later reported flu like symptoms, nasal congestion, cough, sore throat, aching to be non-serious. The event of fever and slight increase platelet  count had been identified by the company physician from the source documents  and added as adverse event and considered it non-serious.
Age: 43.0
Sex: F
Vaccine: FLUN4
Symptoms: Oropharyngeal pain, Pain, Platelet count increased, Pyrexia, Thyroxine normal
Clinical narrative: A report has been received from a Physician concerning a 43 year old female. No medical history and concomitant medications provided. The patient had been receiving FLUMIST QUADRIVALENT 2 ml started on 17 OCT 2014 with Lot number CJ2129 and expiration date was 05-JAN-2015. The patient received FLUMIST QUADRIVALENT and a few days later reported flu like symptoms/flu like symptoms which started on 21-OCT-2014 and nasal congestion, cough, sore throat, aching and fever. The patient had sought increase platelet count which started during 21-OCT-2014. The patient recovered from the event of patient received FLUMIST QUADRIVALENT and a few days later reported flu like symptoms/flu like symptoms on an unspecified date and the outcome of the event of nasal congestion, cough, sore throat, aching, slight increase platelet count and fever was unknown. The reporter considered the events of patient received FLUMIST QUADRIVALENT and a few days later reported flu like symptoms, nasal congestion, cough, sore throat, aching to be non-serious. The event of fever and slight increase platelet  count had been identified by the company physician from the source documents  and added as adverse event and considered it non-serious.
Age: 7.0
Sex: M
Vaccine: FLUN4
Symptoms: Accidental exposure to product, Exposure via direct contact
Clinical narrative: A report has been received from a Pharmacist concerning a 7 year old, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 27-Oct-2014. Patient received a small amount of FLUMIST in his eye which started on 27-Oct-2014. The outcome of the event of patient received a small amount of FLUMIST in his eye is unknown. The report was considered to be non-serious by the reporter.
Age: 12.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report has been received from a Health Professional concerning a 12 year old, male subject, who had been receiving FLUMIST QUADRIVALENT.  FLUMIST QUADRIVALENT started on 23-OCT-2014. It was reported that expired FLUMIST QUADRIVALENT was administered to two patients. The outcome of the e vent EXPIRED FLUMIST QUADRIVALENT administered to two patients is unknown. The report was considered to the non-serious.
Sex: U
Vaccine: FLUN4
Symptoms: Rhinalgia
Clinical narrative: A report has been received from a Physician concerning a child, subject of unknown gender, who had been receiving FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. The patient experienced stinging in nose. The outcome of the event of stinging in nose is unknown. The report was considered to be non-serious.
Age: 42.0
Sex: F
Vaccine: FLUN4
Symptoms: Headache
Clinical narrative: A report has been received from a Health Professional concerning a 42 year old, female subject, who had been receiving FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. The patient experienced developed a headache in the right frontal portion of the head the day after receiving FLUMIST QUADRIVALENT which started on 17-OCT-2014. The patient recovered from the event of developed a headache in the right frontal portion of the head the day after receiving FLUMIST QUADRIVALENT on an  unspecified date. The report was considered to be non-serious.
Age: 8.0
Sex: M
Vaccine: FLUN4
Symptoms: Underdose
Clinical narrative: A spontaneous report has been received from a Health Professional concerning an 08-years-old male patient. No information regarding relevant medical history, concomitant disease or concomitant medication was provided. The patient was receiving FLUMIST QUADRIVALENT started on 22-OCT-2014. The reporter stated that the had a very child and was able to administer half the dose in one nostril which started on 22-OCT-2014. The outcome of the event of administer half the dose in one nostril was unknown. The reporter considered the event administer half the dose in one nostril as non-serious.
Age: 49.0
Sex: F
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Health Professional concerning a 49 year old, female patient, who had been receiving FLUMIST QUADRIVALENT.  FLUMIST QUADRIVALENT started on an unknown  date. It was reported that inadvertently administered FLUMIST QUADRIVALENT to 2 patients over the age of 49 which started on 01-OCT-2014. The outcome of the event  of inadvertent administration of FLUMIST QUADRIVALENT to patient over 49 years of age is unknown. The report was considered to be non-serious.
Age: 86.0
Sex: M
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Health Professional concerning 49 year old, male subject, who had been receiving FLUMIST QUADRIVALENT.  FLUMIST QUADRIVALENT started on an unknown date. The patient was inadvertently administered with FLUMIST QUADRIVALENT at the age over 49 years which started on 01-OCT-2014. The outcome of the event inadvertent administration of FLUMIST QUADRIVALENT to a patient over 49 years of age is unknown. The report was considered to be non-serious.
Age: 40.0
Sex: F
Vaccine: FLUN4
Symptoms: Influenza, Influenza A virus test positive
Clinical narrative: A report has been received from consumer (office manager) concernng a 40 year old female patient. No relevant  history and concomitant medications of the patient were reported. The patient received FLUMIST QUADRIVALVENT on 20-OCT-2014. It was reported that the patient tested positive for influenza A the next day afrter FLUMIST QUADRIVALVENT on 21-OCT-2014 and also experienced flu symptoms. Action taken with FLUMIST QUADRIVALVENT was unknown. At the time of reporting, the events of tested positive for influenza A the nex day after FLUMIST QUADRIVALVENT and flu symptoms were ongoing. The reporter assessed the even tof tested positivie for influenza A the next day after FLUMIST QUADRIVALENT as non-serious and event of flu symptoms was additionally captured by company phyisican and assessed as non-serious.
Sex: U
Vaccine: FLUN4
Symptoms: Influenza A virus test positive, Influenza B virus test positive
Clinical narrative: A report has been received from a Health Professional concerning a patient of unspecified gender. No information regarding relevant history, concomitant disease and concomitant medications were provided. The patient received FLUMIST QUADRIVALENT on 11-OCT-2014. RN reported that a patient tested positive for A and B today on 23-OCT-2014. The outcome of the event of patient tested positive for A and B is unknown. The reports considered the event to be non-serious.
Age: 7.0
Sex: M
Vaccine: FLUN4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: A report has been received from a health professional  concerning a 7 year old male patient. Health professional reported patient received 2 doses on FLUMIST on 02-OCT-2014. Health professional reported there was confusion at a school based clinic and the child inadvertently received 2 doses, patient had not reported any adverse effects. The outcome of the event of patient received two doses of FLUMIST QUADRIVALENT same day was unknown. The reporter was considered the event received two doses of FLUMIST QUADRIVALENT same day to be non-serious. Corrected report 22-OCT-2014. The source of the case was corrected from non-interventional / Post-marketing study to spontaneous and company causality was removed.
Age: 28.0
Sex: F
Vaccine: FLUN4
Symptoms: Drug administration error, Rhinorrhoea
Clinical narrative: A solicited report has been received from a pharmacist concerning a 28 years old female patient. No relevant history, concomitant disease and concomitant medications were reported. Patient had received FLUMIST QUADRIVALENT, unknown dose for unknown indication, started on unknown date. Pharmacist reported that when administering the FLUMIST QUADRIVALENT, the majority of the second dose went into the right nostril. Pharmacist reported that patient developed a runny nose after receiving FLUMIST QUADRIVALENT. The outcome of the events of runny nose and majority of the second dose went into the right nostril was unknown. Reporter considered the events of runny nose and majority of the second dose went into the right nostril to be non serious.
Age: 48.0
Sex: F
Vaccine: FLUN4
Symptoms: Chills, Headache, Myalgia
Clinical narrative: A report has been received from a Physician concerning a 48 year old, female subject, who had been receiving FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 23-SEP-2014. The patient experienced chills, muscle aches and headache. The patient recovered from the event of chills and muscle aches on an unspecified date and at the time of reporting, the event of headache was ongoing. The report was considered to be non-serious.
Sex: M
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report  has been received from a Pharmacist concerning a male subject who had been receiving FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started during 2013. A patient accidentally received expired FLUMIST QUADRIVALENT from the 2013-2014 season which started on 25 SEP-2014. FLUMIST QUADRIVALENT  was discontinued during 2014. The outcome of the event of expired FLUMIST QUADRIVALENT patient accidentally received expired FLUMIST from the 2013-2014 season is unknown. The report was considered to be non-serious.
Age: 4.0
Sex: F
Vaccine: FLUN4
Symptoms: Cough, Insomnia, Nasal congestion
Clinical narrative: A report has been received from a Health Professional concerning a 4 year old, female subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 25-Sep-2014. The patient experienced cough, stuffy nose and not able to sleep which started on 26-Sep-2014. At the time of reporting, the event of cough, stuffy nose and not able to sleep was ongoing. The report was considered to be non-serious by the reporter.
Sex: U
Vaccine: FLUN4
Symptoms: Extra dose administered
Clinical narrative: A report has been received from a Pharmacist concerning a patient of unknown age and gender. On unknown date, the patient had received FLUMIST QUADRIVALENT (intranasal). The patient received double FLUMIST at one time. The outcome of the event of two patients received double FLUMIST at one time was unknown. The report was considered to be non-serious by reporter.
Age: 18.0
Sex: F
Vaccine: FLUN4
Symptoms: Exposure during pregnancy
Clinical narrative: A report has been received from a Health Professional concerning an 18 year old, female patient. Concomitant medications included vitamins NOS. On 30-Sep-2014, the patient had received FLUMIST QUADRIVALENT (intranasal) while she was pregnant. The outcome of the event of FLUMIST administered to pregnant patient was unknown. The patient was pregnant in her second trimester. Her last menstruation was on 25-Apr-2014, and the delivery date will be 28-Jan-2015. The report was considered to be non-serious by reporter.
Sex: M
Vaccine: FLUN4
Symptoms: Drug administration error, Product taste abnormal
Clinical narrative: A report has been received from a health professional who was a registered nurse. The report concerns a male patient in his early twenties. The patient's concomitant medications, concurrent diseases and relevant history were not reported. The patient received FLUMIST QUADRIVALENT (intranasal) at an unknown dose on 01-Oct-2014. The nurse reported that she thought the vaccine was administered correctly with half of dose administered into each nostril. However the patient returned to the student health clinic on the same day o and he felt as though the FLUMIST QUADRIVALENT only went into one nostril and that he could taste the vaccine. She stated that the patient did not report any adverse effects. Action taken with FLUMIST QUADRIVALENT was unknown. At the time of reporting the outcome of the event of feels as though FLUMIST QUADRIVALENT only went into one nostril and he could taste the vaccine was unknown. The company physician changed the event verbatim from FLUMIST QUADRIVALENT only went into one nostril and he could taste the vaccine with verbatim feels as though FLUMIST QUADRIVALENT only went into one nostril and he could taste the vaccine. The report was considered to be non-serious by the company physician.
Age: 46.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report has been received from a Pharmacist concerning a 45 year old, female subject, who had been receiving FLUMIST QUADRIVALENT (Intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. The patient received expired vaccine which started on 01-Dec-2014. The outcome of the event of expired FLUMIST QUADRIVALENT administered was unknown. The report was considered to be non-serious.
Age: 17.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report has been received from a Pharmacist concerning a 17 year old, female subject, who has been receiving FLUMIST QUADRIVAVLENT. FLUMIST QUADRIVALENT stared on an unknown date. The reporter stated that the patient experienced expired FLUMIST which started on 03-DEC-2014. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious.
Age: 6.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report has been received from a Health Professional concerning a 5 year old, male subject, who had been receiving FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. it was reported that the patient experienced three patients inadvertently expired FLUMIST QUADRIVALENT which started on 04-DEC-2014. The outcome of the event of three patient's inadvertently received expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Age: 5.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report has been received from a Health Professional concerning a 5 year old, male subject, who had been receiving FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 02-DEC-2014. the reporter stated that they inadvertently gave expired FLUMIST to three patients on 02-DEC-2014. At the time of reporting, the event of inadvertently gave expired FLUMIST  to three patients was improving. The report was considered to be non-serious.
Age: 4.0
Sex: F
Vaccine: FLUN4
Symptoms: Eye swelling
Clinical narrative: A spontaneous report has been received from a Health Professional concerning a patient born on 17-MAR-2010, female patient. The patient's concurrent disease included seasonal allergies. The patient received FLUMIST QUADRIVALENT on 16-NOV-2014. On 17-NOV-2014, the patient developed swelling around her eyes. The patient was treated with prednisone and clindamycin. The event completely resolved on 22-NOV-2014. The reporter assessed the event of swelling around eye the day after patient received vaccine to be non serious.
Age: 4.0
Sex: M
Vaccine: FLUN4
Symptoms: Joint effusion, Synovial disorder
Clinical narrative: A report has been received from a Health Professional concerning a 4 year old, male subject, who had been receiving FLUMIST QUADRIVALENT.  FLUMIST QUADRIVALENT started on an unknown date. The patient experienced right hip effusion and synovial thickening which started on 04-NOV-2014. The patient recovered from the event of right hip effusion and synovial thickening on an unspecified date. The report was considered to be non-serious.
Sex: U
Vaccine: FLUN4
Symptoms: Incorrect product storage
Clinical narrative: A report has been received from a Health Professional concerning a subject of unknown gender, who had been receiving FLUMIST QUADRIVALENT.  FLUMIST QUADRIVALENT started on an unknown date. It was reported that at pediatrician office they had some FLUMIST QUADRIVALENT that had frozen . Some of the FLUMIST had been administered to about 250 patients. The outcome of the event of frozen FLUMIST QUADRIVALENT and frozen FLUMIST QUADRIVALENT was administered to about 250 patients is unknown. The report was considered to be non-serious.
Age: 14.0
Sex: F
Vaccine: FLUN4
Symptoms: Chest pain, Dyspnoea exertional
Clinical narrative: A consumer report has been received. The report concerns a 14 year old, female consumer, who had been receiving FLUMIST QUADRIVALENT. The patient's medical history included sore throat, cough and sinusitis. Concomitant medications included Budesonide. FLUMIST QUADRIVALENT started on 12-NOV-2014. The patient experienced hard to breath during sports and check pain with exercise. The outcome of the event of hard to breath during sports and chest pain with exercise is unknown. The report was considered to be non-serious.
Sex: M
Vaccine: FLUN4
Symptoms: Ataxia
Clinical narrative: A report has been received from a Health Professional concerning a patient born on 10-MAY-2011, male subject who has been receiving FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. The patient experienced Ataxia. The outcome of Ataxia is unknown. The report was considered to be non-serious.
Age: 52.0
Sex: F
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Health Professional concerning a 52 year old, female subject, who had been receiving FLUMIST QUADRIVALENT.  The patients concurrent disease(s) included Hypothyroidism, Idiopathic sensory neuropathy; Hyperlipidemia and Anxiety. Concomitant medications included Levothyroxine, Montelukast, Omeprazole, Bupropion Hydrochloride, Atorvastatin, Budesonide, Formoterol, Fumarate dihydrate and Fluticasone propionate. FLUMIST QUADRIVALENT started on an unknown date. IT was reported that a 52 years old patient received FLUMIST QUADRIVALENT which started on 06-OCT-2014. The outcome of the event of 52 year old patient received FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Age: 29.0
Sex: F
Vaccine: FLUN4
Symptoms: Exposure during pregnancy
Clinical narrative: A report has been received from a Health Professional concerning a 29 year old, female subject who has been receiving FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 06-OCT-2014. It was reported that on 06-OCT-2014 FLUMIST QUADRIVALENT was administered to pregnant patient. The outcome of event of pregnant patient received FLUMIST QUADRIVALENT is unknown. The outcome of pregnancy was unknown. The report was considered to be non-serious.
Age: 36.0
Sex: F
Vaccine: FLUN4
Symptoms: Exposure during pregnancy
Clinical narrative: A report has been received from a Health Professional concerning a 15 year old, female subject, who had been receiving FLUMIST QUADRIVALENT. Concomitant medications included vitamins NOS. FLUMENT QUADRIVALENT started on 13-NOV-2014. It was reported that the patient was given FLUMIST QUADRIVALENT and she was 11 weeks pregnant which started on 13-NOV-2014. The outcome of the event of FLUMIST QUADRIVALENT administered to a pregnant patient is unknown. The outcome of pregnancy was unknown. The report was considered to be non-serious.
Age: 14.0
Sex: F
Vaccine: FLUN4
Symptoms: Amnesia, Fatigue, Mental status changes, Nausea
Clinical narrative: A report has been received from a Health Professional concerning a 14 year old, female subject, who had been receiving FLUMIST QUADRIVALENT. Concomitant medications included Garcinia Cambogia for supplement. FLUMIST QUADRIVALENT started on an 13-NOV-2014. The patient received FLUMIST QUADRIVALENT yesterday and approximately 30 min's after administration patient experienced fatigue, mental status changes, memory loss, and nausea which started on 13-NOV-2014. At the time of reporting, the event of fatigue, mental status changes-memory loss and nausea was improving. The report was considered to be non-serious.
Age: 1.31
Sex: F
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Health Professional concerning a 1 year old, female subject, who had been receiving FLUMIST QUADRIVALENT.  FLUMIST QUADRIVALENT started on 08-OCT-2014. A 16 month old received FLUMIST QUADRIVALENT. The outcome of the event of 16 month old received FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Age: 26.0
Sex: F
Vaccine: FLUN4
Symptoms: Exposure during pregnancy
Clinical narrative: A report has been received from a Health Professional concerning a 26 year old, female subject,who had been receiving FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 31-OCT-2014. IT was reported that the patient received FLUMIST QUADRIVALENT while pregnant, but at the time of administration, the patient did not know that she was pregnant which started on 31-OCT-2014. The outcome of the event of patient received FLUMIST QUADRIVALENT while pregnant is unknown. Pregnancy outcome was unknown. The report was considered to be non-serious.
Age: 12.0
Sex: F
Vaccine: FLUN4
Symptoms: Influenza A virus test positive, Influenza B virus test positive, Malaise, Pyrexia
Clinical narrative: A report has been received from a  Health Professional concerning a 12 year old, female subject, who had been receiving FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 28-OCT-2014. The patient experienced patient tested positive for influenza A , fever, patient tested positive for influenza B, sick, and not feeling well which started on 28-OCT-2014.  The outcome of the event of patient tested positive for influenza A, fever, patient tested positive for influenza B, sick and not feeling well is  unknown. The report was considered to be non-serious.
Sex: U
Vaccine: FLUN4
Symptoms: Incorrect dose administered
Clinical narrative: A report has been received from a Physician concerning a subject of  unknown gender, who had been receiving FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. Physician had reported that they had inadvertently administered only 1/2 the dose of FLUMIST QUADRIVALENT in one nostril to 199-200 people. The outcome of the event of administered 1/2 the dose of FLUMIST QUADRIVALENT to 199-200 people is unknown. The report was considered to be non-serious.
Sex: M
Vaccine: FLUN4
Symptoms: Drug administration error
Clinical narrative: A report has been received from a health professional concerning a child, male patient,. The patient's medical history and concomitant medication were not reported. The patient had been receiving nasal FLUMIST QUADRIVALENT. The health professional reported that she overheard at her son's school bus the person stated her child received the entire dose of FLUMIST QUADRIVALENT in one nostril. The outcome of the event of patient received entire dose of FLUMIST QUADRIVALENT in one nostril was unknown. The report was considered to be non-serious.
Sex: M
Vaccine: FLUN4
Symptoms: Myalgia
Clinical narrative: A report has been received from a Physician concerning a child, male subject, who had been receiving FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. The patient experienced arm muscle pain. The outcome of arm muscle pain is unknown. The report was considered to be non-serious.
Age: 3.0
Sex: M
Vaccine: FLUN4
Symptoms: Circumstance or information capable of leading to medication error
Clinical narrative: A consumer report has been received. The report concerns a 3 year old, male consumer, who has been receiving FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. It was reported the patient sneezed and liquid came out after first intranasal administration which started on 10-NOV-2014. The outcome of the event of patient sneezed and liquid came out after first intranasal administration is unknown. The report was considered to be non-serious.
Sex: F
Vaccine: FLUN4
Symptoms: Myalgia
Clinical narrative: A report has been received from a Physician concerning an adult, female subject, who had been receiving FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. The patient experienced arm muscle pain. The outcome of arm muscle pain is unknown. The report was considered to be non-serious.